Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

April 10, 2017April 10, 2017

Apricus Advancing RayVa to Phase 2b Trial for Raynaud’s Treatment

News

Apricus Biosciences plans to initiate a Phase 2b study evaluating RayVa (alprostadil), the company’s investigative treatment for Raynaud’s phenomenon. In a press release, the company also announced it is exploring Orphan Drug designation ... Read more

February 8, 2017February 8, 2017

FDA Grants Cytori Therapeutics Small Business Status in the US

News

The U.S. Food and Drug Administration (FDA) has granted Cytori Therapeutics Small Business status designation for fiscal year 2017, meaning that the company will pay reduced fees for regulatory filings that may ... Read more